A214 (Levetiracetam extended release 750 mg)
This pill with imprint "A214" is Yellow, Elliptical / Oval and has been identified as Levetiracetam extended release 750 mg. It is supplied by Anchen Pharmaceuticals, Inc. .
Levetiracetam is used in the treatment of seizures; epilepsy; bipolar disorder; neuralgia; new daily persistent headache (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 750 mg is not a controlled substance under the Controlled Substance Act (CSA).
Levetiracetam extended release
- Imprint:
- A214
- Strength:
- 750 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Pyrrolidine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Anchen Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 10370-0214
More about levetiracetam
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 244 Reviews – Add your own review/rating
- Drug class: pyrrolidine anticonvulsants
Consumer resources
- Levetiracetam Extended-Release Tablets (Keppra XR)
- Levetiracetam Oral-Disintegrating Tablets/Tablets for Oral Suspension
- Levetiracetam Injection
- Levetiracetam Oral Solution
- Levetiracetam Tablets
- ... +3 more
Other brands: Keppra, Keppra XR, Spritam, Roweepra
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
